About the CardioPrevent Program

The CardioPrevent® program is a global risk reduction program that is based on seven years of research conducted through the University of Ottawa Heart Institute by a multidisciplinary team of clinicians and behavioural scientists.

CardioPrevent® provides an evidence-based, tailored primary prevention cardiovascular health program intended for patients at a moderate to high risk of developing cardiovascular disease (CVD).  It provides physicians with a systematic process to screen and identify at risk individuals and link them to a personalized primary prevention program. 

Learn more about the details of the CardioPrevent® Program.


To lower the risk of CVD development in individuals who may be at a moderate to high risk. 


  1. To support health care providers through the deployment of CVD preventive care models to support lifestyle screening, behavioural counseling, and community linkages.  
  2. To improve accessibility to CVD risk screening and risk management through community outreach.